Epigenetic Silencing of miR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC by Targeting Integrin Β3
Oncogene - United Kingdom
doi 10.1038/s41388-018-0276-2
Full Text
Open PDFAbstract
Available in full text
Date
May 2, 2018
Authors
Publisher
Springer Science and Business Media LLC